- Home
- ACB vs OPRX Comparison
ACB vs OPRX Comparison
Compare ACB & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACB
- OPRX
- Stock Information
- Founded
- ACB 2013
- OPRX 2006
- Country
- ACB Canada
- OPRX United States
- Employees
- ACB N/A
- OPRX N/A
- Industry
- ACB Pharmaceuticals and Biotechnology
- OPRX Business Services
- Sector
- ACB Health Care
- OPRX Consumer Discretionary
- Exchange
- ACB Nasdaq
- OPRX Nasdaq
- Market Cap
- ACB 256.5M
- OPRX 234.9M
- IPO Year
- ACB N/A
- OPRX N/A
- Fundamental
- Price
- ACB $5.40
- OPRX $17.59
- Analyst Decision
- ACB
- OPRX Buy
- Analyst Count
- ACB 0
- OPRX 8
- Target Price
- ACB N/A
- OPRX $11.81
- AVG Volume (30 Days)
- ACB 1.7M
- OPRX 382.0K
- Earning Date
- ACB 08-06-2025
- OPRX 08-07-2025
- Dividend Yield
- ACB N/A
- OPRX N/A
- EPS Growth
- ACB N/A
- OPRX N/A
- EPS
- ACB N/A
- OPRX N/A
- Revenue
- ACB $262,403,032.00
- OPRX $104,748,000.00
- Revenue This Year
- ACB $11.13
- OPRX $14.44
- Revenue Next Year
- ACB $5.39
- OPRX $10.63
- P/E Ratio
- ACB N/A
- OPRX N/A
- Revenue Growth
- ACB 28.58
- OPRX 25.89
- 52 Week Low
- ACB $3.42
- OPRX $3.78
- 52 Week High
- ACB $7.20
- OPRX $18.22
- Technical
- Relative Strength Index (RSI)
- ACB 63.62
- OPRX 69.89
- Support Level
- ACB $4.14
- OPRX $12.04
- Resistance Level
- ACB $5.59
- OPRX $18.22
- Average True Range (ATR)
- ACB 0.28
- OPRX 1.30
- MACD
- ACB 0.12
- OPRX 0.50
- Stochastic Oscillator
- ACB 87.93
- OPRX 89.86
About ACB Aurora Cannabis Inc.
Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.